isatin has been researched along with Neuroblastoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abarbri, M; El Qami, A; Frlan, R; Gobec, S; Jismy, B; Knez, D; Kos, J; Pišlar, A | 1 |
| Abdelgawad, MA; Almohaimeed, HM; Benny, F; El-Sherbiny, M; Gahtori, P; Ghoneim, MM; Kim, H; Kumar, S; Manoharan, A; Mathew, B; Oh, JM; Shaker, ME | 1 |
| Hou, L; Hua, Y; Li, N; Li, X; Wang, F; Wang, J; Zhang, J; Zhang, L; Zhang, Z; Zheng, W; Zhou, N | 1 |
| Hou, L; Ju, C; Sun, W; Wei, Y; Zhang, L; Zhao, S | 1 |
| Cao, Y; Hou, L; Ju, C; Sun, W; Wang, X; Zhang, L | 1 |
| Chen, Z; Hou, L; Ju, C; Liu, L; Lv, Y; Song, J; Sun, W; Wang, Y; Xu, P; Zhang, L; Zhang, Z | 1 |
| Ge, Y; Hou, L; Ju, C; Song, J; Yue, W; Zhang, J | 2 |
| Glover, V; Igosheva, N; Lorz, C; Mehmet, H; O'Conner, E | 1 |
| Ge, YL; Hou, L; Song, JL; Yue, W | 1 |
10 other study(ies) available for isatin and Neuroblastoma
| Article | Year |
|---|---|
Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
Topics: Antiparkinson Agents; Bromides; Coordination Complexes; Humans; Indazoles; Metals; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Protein Binding; Small Molecule Libraries; Structure-Activity Relationship; Tyramine | 2021 |
Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Topics: Antipsychotic Agents; Dopamine Agents; Humans; Isatin; Microwaves; Molecular Docking Simulation; Monoamine Oxidase; Neuroblastoma; Pargyline; Parkinson Disease; Pharmacophore | 2023 |
Isatin inhibits the invasion and metastasis of SH‑SY5Y neuroblastoma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclophosphamide; Female; Histone Demethylases; Humans; Isatin; Mice; Molecular Docking Simulation; Neoplasm Invasiveness; Neuroblastoma; Xenograft Model Antitumor Assays | 2021 |
Isatin inhibits SH-SY5Y neuroblastoma cell invasion and metastasis through MAO/HIF-1α/CXCR4 signaling.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isatin; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neoplasm Metastasis; Neuroblastoma; Reactive Oxygen Species; Receptors, CXCR4; Signal Transduction | 2017 |
Isatin inhibits the invasion of human neuroblastoma SH‑SY5Y cells, based on microarray analysis.
Topics: Antineoplastic Agents; Autophagy; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Isatin; Neoplasm Invasiveness; Neuroblastoma; TOR Serine-Threonine Kinases | 2019 |
Isatin inhibits the proliferation and invasion of SH-SY5Y neuroblastoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Isatin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neuroblastoma; Phosphorylation; Protein Processing, Post-Translational; STAT3 Transcription Factor | 2016 |
Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzimidazoles; Blotting, Western; Caspase 3; Cell Line, Tumor; Coloring Agents; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Isatin; Neuroblastoma; Phosphorylation; Propidium; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staining and Labeling; Vascular Endothelial Growth Factor A | 2008 |
Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Female; Humans; Isatin; Mice; Mice, Nude; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
Topics: Annexin A5; Antiparkinson Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isatin; Monoamine Oxidase Inhibitors; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Parkinson Disease; Propidium; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
[Effects of isatin on cell cycle arrest and apoptosis of neuroblastoma cell line SH-SY5Y].
Topics: Apoptosis; Caspase 3; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Isatin; Neuroblastoma; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 | 2008 |